Skip to main content

Table 3 Efficacy of chemotherapy

From: Treatment strategy for reducing the risk of rituximab-induced cytokine release syndrome in patients with intravascular large B-cell lymphoma: a case report and review of the literature

Timing of rituximab administration Number of patients who achieved a complete response Number of patients who did not achieve a complete response Total number of patients
With the first course of chemotherapy 17 3 20
With or after the second course of chemotherapy 9 1 10